Job description

 

• Member of the Translational Cancer Research Group.
• Supervising PhD and postdoc students.
• Extensive experience in experimental, statistical, and computational analysis of cancer, with research expertise in biomarker development, validation, clinical implementation, clinicogenomics, and AI-based pathology.
• Full-time position as leading researcher at the Department of Clinical Pathology, University Hospital of North Norway, Tromsø, responsible for implementing, analyzing, and interpreting next-generation sequencing (NGS) in routine practice. I act as genomicist in the national infrastructure for precision diagnostics in cancer treatment (InPred), IMPRESS-Norway, and TNM-I clinical studies for personalized medicine.
• Part-time position as a senior researcher at the Åslaug Helland Lab, Cancer Genetics Department, Institute of Cancer Research, Oslo University Hospital (OUS), tasked with the development of artificial intelligence-based tools as predictive biomarkers for precision immunotherapy in lung cancer.
• Affiliated collaborator with Brigham and Women’s Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA.
• Honorary and visiting researcher at Imperial College London, UK.